New study shows genes can predict response to arthritis treatment and paves the way for future drug development

New research has shown that molecular profiling of the diseased joint tissue can significantly impact whether specific drug treatments will work to treat rheumatoid arthritis (RA) patients. The researchers also identified specific genes associated with resistance to most available drugs therapies, commonly referred to as refractory disease, which could provide the key to developing new, successful drugs to help these people.
Visit the Source Site

Powered by WPeMatico